Journal of Chromatography A 2012 DOI: 10.1016/j.chroma.2011.12.037 View full text
|
|
Share
Anindya Basu, Susanna Su Jan Leong

Abstract: The Hepatitis B Virus X (HBx) protein is a potential therapeutic target for the treatment of hepatocellular carcinoma. However, consistent expression of the protein as insoluble inclusion bodies in bacteria host systems has largely hindered HBx manufacturing via economical biosynthesis routes, thereby impeding the development of anti-HBx therapeutic strategies. To eliminate this roadblock, this work reports the development of the first 'chromatography refolding'-based bioprocess for HBx using immobilised metal…

expand abstract